Drugs / SJP-0008
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05320861 | Sep → Nov 2021 | — | Senju Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2024-07-08 | Senju Pharmaceutical Co., Ltd. | Regulatory 「SJP-0008」の網膜中心動脈閉塞症に対する希少疾病用医薬品指定のお知らせ senju.co.jp ↗ |
All press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2024-07-08 | Senju Pharmaceutical Co., Ltd. | 「SJP-0008」の網膜中心動脈閉塞症に対する希少疾病用医薬品指定のお知らせ senju.co.jp ↗ |
| 2024-05-09 | Senju Pharmaceutical Co., Ltd. | 網膜中心動脈閉塞症治療薬「SJP-0008」の国内第Ⅲ相臨床試験開始のお知らせ senju.co.jp ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SJP-0008 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05320861 ↗ |
| Route | Oral | “After an Oral Dose” NCT05320861 ↗ |